"Our goal is to provide relief and healing to patients with this terrible disease," said Dr. Bruce Riser, CEO of BLR Bio and ...

OpenAI Has a New AI Model Built for Biology and Science ...

A pioneering DNA scientist reflects on science, faith and purpose, offering a grounded view of how discovery and everyday ...

At its core, GPT-Rosalind is the first in a new series of models optimized for scientific workflows. While previous iterations of GPT excelled at general language tasks, this model is fine-tuned for ...

The GPT-Rosalind model is designed to accelerate biological research and drug discovery. View on euronews ...

On 25 April 1953, Watson and Crick published an article, in the acclaimed journal “Nature” titled “Molecular structure of nucleic acids: A structure for deoxyribonucleic acid”. The one-page article ...

Getting a drug from initial target discovery to U.S. regulatory approval takes between 10 and 15 years on average. Most of ...

Latus Bio, Inc. (Latus), a biotechnology company engineering scalable gene therapies for broader patient populations, today announced the closing of a $97 million Series A financing to support its ...

Rosalind, a biological language model for target discovery and genomics. Currently only available for US corporate customers.

Plan your summer with our calendar. Event details are subject to change due to weather conditions. The Elks Lodge, 2162 ...

What GPT Rosalind is, how OpenAI positions it, where it performs well, and which organizations can use it. A detailed look at ...

OpenAI has released GPT-Rosalind, a large language model fine-tuned specifically for life sciences research, marking the company’s most direct push yet into computational biology and drug discovery.